Inflammasomes in Clinical Practice: A Brief Introduction.

Q2 Medicine
Elísabet Alcocer-Gómez, Beatriz Castejón-Vega, Macarena López-Sánchez, Mario D Cordero
{"title":"Inflammasomes in Clinical Practice: A Brief Introduction.","authors":"Elísabet Alcocer-Gómez,&nbsp;Beatriz Castejón-Vega,&nbsp;Macarena López-Sánchez,&nbsp;Mario D Cordero","doi":"10.1007/978-3-319-89390-7_1","DOIUrl":null,"url":null,"abstract":"<p><p>Inflammasomes are multiprotein complexes formed and activated after exposure to pathogenic microbes and host danger signals that control the maturation and production of IL-1β and IL-18. Their implication in different diseases such as cardiovascular, neurodegenerative, psychiatric, and metabolic diseases opens a door to developing new therapeutic perspectives. However, the rapid increase in the knowledge about inflammasomes is associated with their involvement in clinical practice. Two topics open the way to future lines of research: a clinical trial with the new specific inhibitors and the development of diagnostic tools.</p>","PeriodicalId":36906,"journal":{"name":"Experientia supplementum (2012)","volume":"108 ","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/978-3-319-89390-7_1","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experientia supplementum (2012)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-319-89390-7_1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3

Abstract

Inflammasomes are multiprotein complexes formed and activated after exposure to pathogenic microbes and host danger signals that control the maturation and production of IL-1β and IL-18. Their implication in different diseases such as cardiovascular, neurodegenerative, psychiatric, and metabolic diseases opens a door to developing new therapeutic perspectives. However, the rapid increase in the knowledge about inflammasomes is associated with their involvement in clinical practice. Two topics open the way to future lines of research: a clinical trial with the new specific inhibitors and the development of diagnostic tools.

炎性小体在临床中的应用:简介。
炎性小体是暴露于病原微生物和宿主危险信号后形成和激活的多蛋白复合物,控制IL-1β和IL-18的成熟和产生。它们在心血管疾病、神经退行性疾病、精神疾病和代谢性疾病等不同疾病中的应用为开发新的治疗前景打开了大门。然而,关于炎性小体的知识的迅速增加与它们在临床实践中的参与有关。两个主题为未来的研究开辟了道路:新的特异性抑制剂的临床试验和诊断工具的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Experientia supplementum (2012)
Experientia supplementum (2012) Medicine-Medicine (all)
CiteScore
3.30
自引率
0.00%
发文量
24
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信